| Name | N-(5-{4-[(1,1-Dioxido-4-thiomorpholinyl)methyl]-3-fluorophenyl}imidazo[1,2-a]pyridin-2-yl)cyclopropanecarboxamide |
|---|---|
| Synonyms |
N-(5-{4-[(1,1-Dioxido-4-thiomorpholinyl)methyl]-3-fluorophenyl}imidazo[1,2-a]pyridin-2-yl)cyclopropanecarboxamide
MFCD30530428 |
| Description | JAK1-IN-8, a potent JAK1 inhibitor (IC50<500 nM), compound 28, extracted from patent WO2016119700A1[1]. |
|---|---|
| Related Catalog | |
| Target |
JAK1:<500 nM (IC50) JAK2:500-1000 nM (IC50) JAK3:>5000 nM (IC50) |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Molecular Formula | C22H23FN4O3S |
| Molecular Weight | 442.51 |
| Exact Mass | 442.147491 |
| LogP | 1.05 |
| Index of Refraction | 1.712 |